Skip to main content
. 2021 Feb 26;15:15. doi: 10.1186/s40246-021-00314-7

Fig. 2.

Fig. 2

CXCL16 modulated cell viability of human neonatal cardiomyocytes treated with H/R. a, b After si-CXCL16#1 and si-CXCL16#2 transfections, CXCL16 expression was measured at both mRNA and protein levels using qRT-PCR and western blot assays, n = 3 independent experiments. **P < 0.01 vs. si-con. c, d qRT-PCR and western blot assays revealed the expression of CXCL16 after the transfection of pcDNA3.1-CXCL16, n = 3 independent experiments. **P < 0.01 vs. vector. e, f Cell viability was measured using CCK-8 analysis, n = 3 independent experiments. **P < 0.01 vs. control, ##P < 0.01 vs. H/R. All data were exhibited as mean ± standard deviation (SD)